1. Serum caffeine concentrations in preterm infants: a retrospective study
- Author
-
Masashiro Sugino, Toru Kuboi, Yuta Noguchi, Katsufumi Nishioka, Yoko Tadatomo, Nana Kawaguchi, Takaaki Sadamura, Akiko Nakano, Yukihiko Konishi, Kosuke Koyano, Shinji Nakamura, Hitoshi Okada, Susumu Itoh, and Takashi Kusaka
- Subjects
Medicine ,Science - Abstract
Abstract Therapeutic drug monitoring is generally unnecessary in caffeine treatment for apnea of prematurity, as serum caffeine concentrations in preterm infants are normally markedly lower than those at which caffeine intoxication occurs. However, several studies have reported preterm infants having developed toxicity. This retrospective observational study, conducted at a tertiary center in Kagawa, Japan, aimed to evaluate the correlation between the maintenance dose and serum caffeine concentrations and determine the maintenance dose leading to suggested toxic caffeine levels. We included 24 preterm infants (gestational age, 27 ± 2.9 weeks; body weight, 991 ± 297 g) who were treated with caffeine citrate for apnea of prematurity between 2018 and 2021, and 272 samples were analyzed. Our primary outcome measure was the maintenance dose leading to suggested toxic caffeine levels. We found a positive correlation between caffeine dose and serum caffeine concentrations (p
- Published
- 2023
- Full Text
- View/download PDF